NCT04093895View on ClinicalTrials.gov

Trial to Evaluate Safety, Tolerability, Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

June 10, 2020

Study Completion Date

September 25, 2020

Conditions
Periodontitis
Interventions
DRUG

PerioSept(r)

Scaling and root planing followed by 3% PerioSept(r) administration

Trial Locations (1)

77063

Perio Health Professionals, Houston

Sponsors
All Listed Sponsors
lead

Geistlich Pharma AG

INDUSTRY

NCT04093895 - Trial to Evaluate Safety, Tolerability, Efficacy of PerioSept® as Adjunct to SRP in Subjects With Periodontitis | Biotech Hunter | Biotech Hunter